FarmPharma AB (publ), which is a subsidiary of Double Bond Pharmaceutical International AB (publ), has today reported that the third recombinant bovine interferon that is an ingredient in FarmPharma’s product InterferOX is manufactured in two forms: one in natural form and the other genetically modified. FarmPharma will choose which one to include in InterferOX, based on their biological activity.
“The development of antiviral agents with innovative mechanisms of action is becoming more and more relevant, – comments Igor Lokot, SO at FarmPharma, – We are very pleased that with the production of the third interferon we have achieved an important milestone in the development of InterferOX. “
The first interferons were manufactured earlier this year: link
According to the plan, InterferOX will consist of 3-5 different types of interferons.